| NCT ID | NCT03332966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Finnish Institute for Health and Welfare |
| Condition | Psychotic Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2019-12-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2019-12-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to identify unusual experiences and psychiatric symptoms that indicate a heightened risk for severe mental disorders - especially psychoses. It is important to develop reliable questionnaire methods that are cost-effective in first-stage screening, leading to in-depth assessments and targeted care. However, existing psychosis-risk questionnaires are limited in content, intended for adults, and have been insufficiently tested for actual predictive value. Therefore we will collect a new, large dataset from an unselected group of adolescents entering psychiatric care in three major urban areas of Finland. Comprehensive national health care registers will be used to assess how well the selected experiences and symptoms predict the participants' mental health over the following few years.
Eligibility Criteria
Inclusion Criteria: Start of care in adolescent mental health clinic Exclusion Criteria: Previous diagnosis of psychotic disorder
Contact & Investigator
Sebastian Therman, PhD
STUDY DIRECTOR
Sebastian.Therman@THL.fi
Frequently Asked Questions
Who can join the NCT03332966 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 18 Years, studying Psychotic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03332966 currently recruiting?
Yes, NCT03332966 is actively recruiting participants. Contact the research team at Sebastian.Therman@THL.fi for enrollment information.
Where is the NCT03332966 trial being conducted?
This trial is being conducted at Helsinki, Finland, Oulu, Finland, Tampere, Finland.
Who is sponsoring the NCT03332966 clinical trial?
NCT03332966 is sponsored by Finnish Institute for Health and Welfare. The principal investigator is Sebastian Therman, PhD at Sebastian.Therman@THL.fi. The trial plans to enroll 1,000 participants.